Roeland Van Aelst

Roeland joined Johnson & Johnson in 1987 as a Medical Representative for Janssen Pharmaceuticals. He held various positions of increasing responsibility in both sales and marketing and joined the Compliance organization of Johnson & Johnson in May 2005 for the EMEA region with extension to Asia, Latin-America and Canada in 2008. In 2010 Roeland became responsible for EMEA & Canada cross sector.  His current position since October 2012 is Regional Vice President - HCC MD EMEA. He is also the Chairman of the MedTech Europe Ethics and Compliance Committee. Roeland is a founding member and the current president of ETHICS, an international association of Health Care Compliance professionals.

This blog is part of the GMTCC 2018 blog series. You can follow the conversation under #GMTCC and find more details and at gmtcc.com . Check out related blogs: Swifter, Higher, Stronger: Promoting MedTech Ethics on the Global Stage , How to create and maintain an ethical culture , Global Responsibility, Global Ethics and Compliance, Global Principles for MedTech Innovation , Distributors play key role in compliance, New industry code must safeguard independent medical education and Health data can transform our lives-but must be used wisely The Global MedTech Compliance Conference (GMTCC) in Paris, 2-4 May 2018, provided a moment to reflect on how far our industry has travelled on our shared compliance journey, and to consider what we need to do to ensure greater global alignment on codes of ethics. It is 10 years since the first GMTCC in Paris. Back then, one of our first tasks was to compare and contrast different codes of ethics around the world. We have worked hard to align the principles underpinning the codes applied around the globe ever since. We have made significant progress on global harmonisation. Nowhere is this better evidenced than in the agreement by the 26-member associations of the Global Medical Technology Alliance to a set of key principles. This huge milestone promises greater convergence within our industry and points the way towards better alignment with the other sectors active in healthcare. (The full announcement could be found here .) A changed landscape The world has changed since we first met in Paris a decade ago – and so has our industry. Smartphones had just been launched; mobile health apps were almost unheard of; value-based healthcare was in its infancy. “As our products and business-models evolve so must our approaches to compliance. This does not mean deviating from the...